Ticker Details
Heron Therapeutics, Inc. Heron Therapeutics Inc is a biotechnology company, developing products to address unmet medical needs. It is developing novel, patient-focused solutions that apply its science and technologies to already-approved pharmacological agents.
IPO Date:	January 23, 2014
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$60.41M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.40 | 3.50%
Avg Daily Range (30 D):	$0.02 | 4.20%
Avg Daily Range (90 D):	$0.03 | 4.86%

Institutional Daily Volume
Avg Daily Volume:	1.33M
Avg Daily Volume (30 D):	2.65M
Avg Daily Volume (90 D):	2.92M

Trade Size
Avg Trade Size (Sh.):	171
Avg Trade Size (Sh.) (30 D):	319
Avg Trade Size (Sh.) (90 D):	341

Institutional Trades
Total Institutional Trades:	3,474
Avg Institutional Trade:	$1.58M
Avg Institutional Trade (30 D):	$.91M
Avg Institutional Trade (90 D):	$.71M
Avg Institutional Trade Volume:	.13M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$2.02M
Avg Closing Trade (30 D):	$.91M
Avg Closing Trade (90 D):	$.91M
Avg Closing Volume:	182.09K

News

Oct 29, 2025 @ 9:58 PM Heron Therapeutics Announces Appointment of Thomas... Source: Craig Collard

Oct 29, 2024 @ 8:05 PM Heron Therapeutics to Report Third Quarter 2024 Fi... Source: Prnewswire

Sep 17, 2024 @ 10:00 AM Chemotherapy Induced Nausea and Vomiting Treatment... Source: Fact.Mr

Jul 2, 2024 @ 12:43 PM Merck (MRK) Gets Exclusive Rights to Opevesostat F... Source: Zacks Equity Research

Jul 1, 2024 @ 2:31 PM FDA Rejects Rocket's (RCKT) Gene Therapy BLA for R... Source: Zacks Equity Research

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-.18	$-.03	$-.04
Diluted EPS	$-.18	$-.03	$-.04
Revenue	$151.18M	$37.67M	$34.71M
Gross Profit	$105.94M	$26.09M	$24.07M
Net Income / Loss	$-34.05M	$-5.49M	$-8.11M
Operating Income / Loss	$-10.86M	$-2.04M	$-4.77M
Cost of Revenue	$45.24M	$11.57M	$10.64M
Net Cash Flow	$4.21M	$-5.4M	$-2.53M
PE Ratio

Splits
Jan 13, 2014	1:20
May 25, 2007	1:4